πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9732095

Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

Aurigene Discovery Technologies Limited Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9732070

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9725470

Substituted naphthyridines as JAK kinase inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9725448

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9724359

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9724350

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitor

Agios Pharmaceuticals, Inc. Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9718827

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9714244

Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors

ALMAC DISCOVERY LIMITED Β· Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9708296

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9707221

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9707215

Inhibitors of hepatitis C virus polymerase

COCRYSTAL, DISCOVERY, INC. Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9701674

Substituted pyrazines as ATR kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9701661

2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric ox

Northwestern University Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9693999

Small molecule RNase inhibitors and methods of use

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688722

Substrates and inhibitors of prolyl oligopeptidase and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688710

Inhibitors of sodium glucose cotransporter 1

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688697

RNA polymerase I inhibitors and uses thereof

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688692

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688616

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9687489

Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9683002

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682982

Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of th

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682976

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682052

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted